These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22932283)

  • 1. Predicting and characterizing selective multiple drug treatments for metabolic diseases and cancer.
    Facchetti G; Zampieri M; Altafini C
    BMC Syst Biol; 2012 Aug; 6():115. PubMed ID: 22932283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico drug combination discovery for personalized cancer therapy.
    Jeon M; Kim S; Park S; Lee H; Kang J
    BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A memetic algorithm for multiple-drug cancer chemotherapy schedule optimization.
    Tse SM; Liang Y; Leung KS; Lee KH; Mok TS
    IEEE Trans Syst Man Cybern B Cybern; 2007 Feb; 37(1):84-91. PubMed ID: 17278562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mathematical model of combination therapy using the EGFR signaling network.
    Araujo RP; Petricoin EF; Liotta LA
    Biosystems; 2005 Apr; 80(1):57-69. PubMed ID: 15740835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles.
    Li X; Xu Y; Cui H; Huang T; Wang D; Lian B; Li W; Qin G; Chen L; Xie L
    Artif Intell Med; 2017 Nov; 83():35-43. PubMed ID: 28583437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive Behaviors of Druggable Proteins in Cellular Networks.
    Mitsopoulos C; Schierz AC; Workman P; Al-Lazikani B
    PLoS Comput Biol; 2015 Dec; 11(12):e1004597. PubMed ID: 26699810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data.
    Celebi R; Bear Don't Walk O; Movva R; Alpsoy S; Dumontier M
    Sci Rep; 2019 Jun; 9(1):8949. PubMed ID: 31222109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy.
    Liu H; Zhang W; Zou B; Wang J; Deng Y; Deng L
    Nucleic Acids Res; 2020 Jan; 48(D1):D871-D881. PubMed ID: 31665429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors.
    Ocaña A; Freedman O; Amir E; Seruga B; Pandiella A
    Cancer Metastasis Rev; 2014 Mar; 33(1):295-307. PubMed ID: 24338003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal control nodes in disease-perturbed networks as targets for combination therapy.
    Hu Y; Chen CH; Ding YY; Wen X; Wang B; Gao L; Tan K
    Nat Commun; 2019 May; 10(1):2180. PubMed ID: 31097707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DrugComboRanker: drug combination discovery based on target network analysis.
    Huang L; Li F; Sheng J; Xia X; Ma J; Zhan M; Wong ST
    Bioinformatics; 2014 Jun; 30(12):i228-36. PubMed ID: 24931988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network Propagation Predicts Drug Synergy in Cancers.
    Li H; Li T; Quang D; Guan Y
    Cancer Res; 2018 Sep; 78(18):5446-5457. PubMed ID: 30054332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards the routine use of in silico screenings for drug discovery using metabolic modelling.
    Bintener T; Pacheco MP; Sauter T
    Biochem Soc Trans; 2020 Jun; 48(3):955-969. PubMed ID: 32369553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A methodology for finding optimal dosage levels in multi-drug treatment interactions.
    Barbosa M de Matos
    Comput Methods Programs Biomed; 1994 Jun; 43(3-4):239-45. PubMed ID: 7956165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interaction prediction using ontology-driven hypothetical assertion framework for pathway generation followed by numerical simulation.
    Arikuma T; Yoshikawa S; Azuma R; Watanabe K; Matsumura K; Konagaya A
    BMC Bioinformatics; 2008 May; 9 Suppl 6(Suppl 6):S11. PubMed ID: 18541046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.
    Vemuri VK; Janero DR; Makriyannis A
    Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing combination therapies with modeling chaperoned machine learning.
    Zhang Y; Huynh JM; Liu GS; Ballweg R; Aryeh KS; Paek AL; Zhang T
    PLoS Comput Biol; 2019 Sep; 15(9):e1007158. PubMed ID: 31498788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.